Intensive Blood Pressure Lowering in Patients With and Patients Without Type 2 Diabetes: A Pooled Analysis From Two Randomized Trials
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The Action to Control Cardiovascular Risk in Diabetes Blood Pressure (ACCORD-BP) study did not find a significant beneficial effect of intensive systolic blood pressure (SBP) lowering on cardiovascular events in hypertensive patients with type 2 diabetes mellitus (T2DM), while the Systolic Blood Pressure Intervention Trial (SPRINT) did find a significant beneficial effect in patients without T2DM. The objective of this analysis was to assess the effect of both T2DM and baseline cardiovascular disease risk on the treatment effect of intensive blood pressure lowering. RESEARCH DESIGN AND METHODS: The individual patient data from the ACCORD-BP and SPRINT studies were pooled and follow-up durations harmonized. Both studies randomized hypertensive patients to an SBP target of <120 mmHg or a target of <140 mmHg. The composite primary end point consisted of unstable angina, myocardial infarction, acute heart failure, stroke, and cardiovascular death. The interaction between intensive blood pressure lowering and both T2DM and 10-year cardiovascular risk was assessed using Cox proportional hazards models. RESULTS: The cohort consisted of 14,094 patients with mean age 66 ± 8.9 years and mean baseline SBP 139.5 ± 15.6 mmHg; 33.6% had T2DM. The hazard ratio for the primary composite end point was 0.82 (95% CI 0.73–0.93), P = 0.0017. The interaction between intensive blood pressure lowering and T2DM was nonsignificant (P = 0.13). The 10-year cardiovascular risk was higher in primary prevention patients with T2DM, but risk did not interact with the treatment effect (P = 0.84). CONCLUSIONS: Intensive blood pressure lowering may have a similar favorable effect and appears to decrease cardiovascular events in both patients with and patients without T2DM.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Routine use of ABPM may be considered for the evaluation of white-coat hypertension, masked hypertension, and nighttime nondipping status, all of which are associated with increased long-term morbidity and mortality.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [230]
Citations
Cites
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Global burden of hypertension: analysis of worldwide data
Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K., & He, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17741-1 · Cited by 8,594
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491 · cited 1×
“The 10-year risk score of CVD was calculated in the subset of patients without a history of cardiovascular events (12).”
MethodA Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Effects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598
Huxley, R., Barzi, F., & Woodward, M. (2006) · BMJ · doi:10.1136/bmj.38678.389583.7c · Cited by 1,534
Cardiorenal end points in a trial of aliskiren for type 2 diabetes
Parving, H.-H., Brenner, B. M., McMurray, J. J. V., de Zeeuw, D., Haffner, S. M., Solomon, S. D., Chaturvedi, N., Persson, F., Desai, A. S., Nicolaides, M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1208799 · Cited by 1,319
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes
Haller, H., Ito, S., Izzo, J. L., Januszewicz, A., Katayama, S., Menne, J., Mimran, A., Rabelink, T. J., Ritz, E., Ruilope, L. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007994 · Cited by 792
Diabetes and hypertension: a position statement by the American Diabetes Association
de Boer, I. H., Bangalore, S., Benetos, A., Davis, A. M., Michos, E. D., Muntner, P., Rossing, P., Zoungas, S., & Bakris, G. (2017) · Diabetes Care · doi:10.2337/dci17-0026 · Cited by 714 · cited 2×
“(25th, 75th) 32 (22, 45) 22 (15, 32) 25 (17, 36) 25 (17, 37) 0.”
Background
Research works printed but not linked: 1
- 1989, Hypertension, 13, 2
Cited by
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae178 · Cited by 2,298
Zhou, B., Perel, P., Mensah, G. A., & Ezzati, M. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00559-8 · Cited by 1,521
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s010 · Cited by 869
Joseph, J. J., Deedwania, P., Acharya, T., Aguilar, D., Bhatt, D. L., Chyun, D. A., Di Palo, K. E., Golden, S. H., Sperling, L. S., & on behalf of the American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Arteriosclerosis, T. A. V. B. C. O. C. C. A. C. O. H. (2022) · Circulation · doi:10.1161/cir.0000000000001040 · Cited by 660
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s010 · Cited by 495
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s010 · Cited by 487
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s010 · Cited by 471
Beddhu, S., Greene, T., Boucher, R., Cushman, W. C., Wei, G., Stoddard, G., Ix, J. H., Chonchol, M., Kramer, H., Cheung, A. K., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30099-8 · Cited by 128
Beddhu, S., Chertow, G. M., Greene, T., Whelton, P. K., Ambrosius, W. T., Cheung, A. K., Cutler, J., Fine, L., Boucher, R., Wei, G., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009326 · Cited by 117
Banerjee, D., Winocour, P. H., Chowdhury, T. A., De, P., Wahba, M. M., Montero, R., Fogarty, D. G., Frankel, A., Karalliedde, J. J., Mark, P. B., et al. (2022) · BMC Nephrology · doi:10.1186/s12882-021-02587-5 · Cited by 107
Muntner, P., Whelton, P. K., Woodward, M., & Carey, R. M. (2018) · Diabetes Care · doi:10.2337/dc18-1307 · Cited by 64
Clinical practice guideline for the management of hypertension in China
Chinese Society of Cardiology, C. M. A., Hypertension Committee of Cross-Straits Medicine Exchange Association, & Cardiovascular Disease Prevention and Rehabilitation Committee, C. A. O. R. M. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003431 · Cited by 68
Collard, D., Brouwer, T. F., Olde Engberink, R. H. G., Zwinderman, A. H., Vogt, L., & van den Born, B.-J. H. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.14659 · Cited by 61
Self-citationBuckley, L. F., Dixon, D. L., Wohlford, G. F., Wijesinghe, D. S., Baker, W. L., & Van Tassell, B. W. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13248 · Cited by 42
Tsujimoto, T., & Kajio, H. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11408 · Cited by 38
KDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline
Kramer, H., Townsend, R. R., Griffin, K. A., Flynn, J. T., Weiner, D. E., Rocco, M. V., Choi, M. J., Weir, M. R., Chang, T. I., Agarwal, R., et al. (2019) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.01.007 · Cited by 38
Xie, L., & Wenfang, X. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120543 · Cited by 36
SGLT2 inhibitors, sodium and off-target effects: an overview
Pascalis, A. D., Cianciolo, G., Capelli, I., Brunori, G., & Manna, G. L. (2020) · Journal of Nephrology · doi:10.1007/s40620-020-00845-7 · Cited by 32
Diabetes and Hypertension: Clinical Update
Khangura, D., Kurukulasuriya, L. R., Whaley‐Connell, A. T., & Sowers, J. R. (2018) · American Journal of Hypertension · doi:10.1093/ajh/hpy025 · Cited by 27
Tian, J., Sheng, C., Sun, W., Song, X., Wang, H., Li, Q., Li, W., & Wang, W. (2018) · Diabetes Care · doi:10.2337/dc18-0918 · Cited by 28
Verma, S., Leiter, L. A., Zinman, B., Sharma, A., Mattheus, M., FITCHETT, D. H., George, J. T., Ofstad, A. P., Kosiborod, M., Wanner, C., et al. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13374 · Cited by 24
Siddiqi, T. J., Usman, M., Siddiqui, A., Salman, A., Talbot, N., Khan, L. A., Shabbir, A., Hall, M. E., & Taffet, G. E. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.102131 · Cited by 18
International Guidelines for Hypertension: Resemblance, Divergence and Inconsistencies
Justin, J., Fayol, A., Bruno, R. M., Khettab, H., & Boutouyrie, P. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11071975 · Cited by 15
Cheng, Y., Wang, D., Yang, Y., Miao, Y., Shen, W., Tian, J., & Sheng, C. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110831 · Cited by 14
Current Approaches in the Administration of Chronic Complications Related to Diabetes
Yuksel, M., & Bektaş, H. (2020) · Turkiye Klinikleri Journal of Nursing Sciences · doi:10.5336/nurses.2019-70201 · Cited by 13
Reevaluating the Evidence for Blood Pressure Targets in Type 2 Diabetes
Lamprea-Montealegre, J. A., & de Boer, I. H. (2018) · Diabetes Care · doi:10.2337/dci17-0063 · Cited by 11
Yang, R., Bai, J., Fang, Z., Wang, Y., Feng, Y., Liu, Y., Chi, H., Deng, Y., Song, Q., & Cai, J. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14927 · Cited by 10
Wang, Z., Yu, C., Cao, X., He, Y., & Ju, W. (2023) · Journal of Clinical Hypertension · doi:10.1111/jch.14646 · Cited by 10
Zhang, Y., Liang, M., Sun, C., Qu, G., Shi, T., Min, M., Wu, Y., & Sun, Y. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0221-z · Cited by 7
Fan, L., Pan, J., Lin, H., Wang, C., Zhang, J., & Gu, J. (2020) · Internal Medicine Journal · doi:10.1111/imj.15006 · Cited by 7
Tsujimoto, T., & Kajio, H. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13886 · Cited by 6
Madhi, R., Hashim, N. A., AL-ALI, Z. A. J. R., & Tahir, N. T. (2024) · Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale · doi:10.4081/jbr.2024.12484 · Cited by 5
Yang, R., Wang, Y., Tong, A., Yu, J., Zhao, D., & Cai, J. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.04.019 · Cited by 5
Schernthaner, G., Saely, C. H., Schernthaner, G.-H., Watschinger, B., & Drexel, H. (2019) · Wiener klinische Wochenschrift · doi:10.1007/s00508-019-1460-2 · Cited by 3
Glycemic status and the association of change in blood pressure with incident cardiovascular disease
Suzuki, Y., Kaneko, H., Yano, Y., Okada, A., Itoh, H., Matsuoka, S., Fujiu, K., Michihata, N., Jo, T., Takeda, N., et al. (2022) · American Heart Journal · doi:10.1016/j.ahj.2022.07.005 · Cited by 3
McEvoy, J. W., McCarthy, C. P., Brouwers, S., & Others, A. (2025) · HYPERTENSION · doi:10.22141/2224-1485.17.4.2024.372 · Cited by 2
Thompson, B., & McEvoy, J. W. (2021) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2021.2013814 · Cited by 1
Saely, C. H., Schernthaner, G.-H., Brix, J. M., Klauser‐Braun, R., Zitt, E., Drexel, H., & Schernthaner, G. (2023) · Wiener klinische Wochenschrift · doi:10.1007/s00508-023-02189-1 · Cited by 1
Fava, M. C., Reiff, S., Azzopardi, J., & Fava, S. (2023) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2023.102777 · Cited by 1
Dual-therapy stent technology for patients with coronary artery disease : A great catch?
Kalkman, D. N. (2018) · Data Archiving and Networked Services (DANS) · Cited by 1
Self-citationKalkman, D. N., Brouwer, T. F., & van den Born, B. H. (2018) · Circulation · doi:10.1161/circulationaha.118.034135 · Cited by 1
Self-citationSposito, A. C., & Junior, C. V. S. (2019) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.65.1.1 · Cited by 1
Cheng, Y., Wang, D., Yang, Y., Miao, Y., Tian, J., & Sheng, C. (2022) · Research Square · doi:10.21203/rs.3.rs-1943479/v1
Uduakobong, O. B., Abigail, A., Mariam, S., & Gazuwa, S. Y. (2023) · Asian Journal of Biochemistry Genetics and Molecular Biology · doi:10.9734/ajbgmb/2023/v14i4320
Ispitivanje faktora neadherence lekova u populaciji bolesnika sa arterijskom hipertenzijom
Nikolić, A. (2023) · National Repository of Dissertations in Serbia
Cardiovascular health across the glycemic spectrum Kan
Wang, K. (2023) · EUR Research Repository (Erasmus University Rotterdam)
Modelling in hypertension: From basic physiology to advanced epidemiology
Collard, D. (2022) · Pure Amsterdam UMC
Saely, C. H., Schernthaner, G.-H., Brix, J. M., Klauser‐Braun, R., Zitt, E., Drexel, H., & Schernthaner, G. (2026) · Wiener klinische Wochenschrift · doi:10.1007/s00508-026-02719-7
Metadata
- Authors
- Brouwer, T. F., Vehmeijer, J. T., Kalkman, D. N., Berger, W. R., van den Born, B.-J. H., Peters, R. J., & Knops, R. E.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Department of Internal and Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
- Corresponding author
- Brouwer, Tom F.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2017-12-06
- Volume
- 41
- Issue
- 6
- Pages
- 1142-1148
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2774272272
- Cited by
- 44
- References
- 17
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 7 · 2022: 8 · 2021: 4 · 2020: 4 · 2019: 6 · 2018: 10
- FWCI
- 4.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- intensive blood pressure lowering, systolic blood pressure target, type 2 diabetes, hypertension, cardiovascular events, sprinting, cardiovascular risk, treatment effect heterogeneity, primary prevention, myocardial infarction, stroke, heart failure
- MeSH terms
- Aged, Antihypertensive Agents, Blood Pressure, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Heart Failure, Humans, Hypertension, Male, Middle Aged, Myocardial Infarction, Systole, Cohort Studies, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Treatment Outcome, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.